10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The survivin suppressant YM155 potentiates chemosensitivity to gemcitabine in the human pancreatic cancer cell line MiaPaCa-2.

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Survivin is a negative regulator of apoptosis. We evaluated the efficacy of YM155, a selective suppressant of survivin, in combination with gemcitabine in the pancreatic cancer cell line MiaPaCa-2.

          Related collections

          Author and article information

          Journal
          Anticancer Res.
          Anticancer research
          1791-7530
          0250-7005
          May 2012
          : 32
          : 5
          Affiliations
          [1 ] Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
          Article
          32/5/1681
          22593446
          023d10e9-ec69-4d0d-8ff9-a175fd9bae4a
          History

          Comments

          Comment on this article